BC

Birchview Capital Portfolio holdings

AUM $101M
1-Year Return 34.62%
This Quarter Return
+12.02%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$142M
AUM Growth
+$4.53M
Cap. Flow
+$1.44M
Cap. Flow %
1.01%
Top 10 Hldgs %
70.5%
Holding
66
New
2
Increased
5
Reduced
4
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STOK icon
51
Stoke Therapeutics
STOK
$1.08B
$193K 0.14%
15,000
IFRX icon
52
InflaRx
IFRX
$106M
$185K 0.13%
70,000
CNCE
53
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$134K 0.09%
20,000
ATEC icon
54
Alphatec Holdings
ATEC
$2.45B
$87K 0.06%
+10,000
New +$87K
YTEN
55
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$56K 0.04%
781
LSF icon
56
Laird Superfood
LSF
$61M
$51K 0.04%
28,000
ELTX icon
57
Elicio Therapeutics
ELTX
$177M
$50K 0.04%
5,439
CFRX
58
DELISTED
ContraFect Corporation
CFRX
$34K 0.02%
2,500
SIEN
59
DELISTED
Sientra, Inc.
SIEN
$26K 0.02%
4,000
AWH
60
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$22K 0.02%
4,005
-1,535
-28% -$8.43K
VNDA icon
61
Vanda Pharmaceuticals
VNDA
$274M
0
ZNTL icon
62
Zentalis Pharmaceuticals
ZNTL
$128M
-8,000
Closed -$225K
TPTX
63
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-8,000
Closed -$602K
AKBA icon
64
Akebia Therapeutics
AKBA
$801M
0
AMRN
65
Amarin Corp
AMRN
$311M
0
BIIB icon
66
Biogen
BIIB
$20.5B
0